АЛГОРИТМЫ ЛОКАЛЬНОЙ ТЕРАПИИ УЛЬТРАНИЗКИМИ ДОЗАМИ ЭСТРИОЛА И ЛАКТОБАЦИЛЛАМИ В АКУШЕРСКО-ГИНЕКОЛОГИЧЕСКОЙ ПРАКТИКЕ

1. Kwon M.S., Lee H.K. Host and microbiome interplay shapes the vaginal microenvironment. Front. Immunol. 2022; 13: 919728. https://dx.doi.org/10.3389/ fimmu.2022.919728

2. Jenkins D.J., Woolston B.M., Hood-Pishchany M.I., Pelayo P., Konopaski A.N., Quinn Peters M. et al. Bacterial amylases enable glycogen degradation by the vaginal microbiome. Nat. Microbiol. 2023; 8(9): 1641-52. https://dx.doi.org/10.1038/s41564-023-01447-2

3. Kaufman M.R., Ackerman A.L., Amin K.A., Coffey M., Danan E., Faubion S.S. et al. The AUA/SUFU/AUGS Guideline on Genitourinary Syndrome of Menopause. J. Urol. 2025; 214(3): 242-50. https://dx.doi.org/10.1097/JU.0000000000004589

4. Faubion S., Crandall C.J., Davis L., El Khoudary S., Hodis H., Lobo R.A. et al. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022; 29(7): 767-94. https://dx.doi.org/10.1097/GME.0000000000002028

5. Srinivasan S., Hua X., Wu M.C., Proll S., Valint D.J., Reed S.D. et al. Impact of topical interventions on the vaginal microbiota and metabolome in postmenopausal women: A secondary analysis of a randomized clinical trial. JAMA Netw. Open. 2022; 5(3): e225032. https://dx.doi.org/10.1001/jamanetworkopen.2022.5032

6. Zeng Q., Shu H., Pan H., Zhang Y., Fan L., Huang Y. et al. Associations of vaginal microbiota with the onset, severity, and type of symptoms of genitourinary syndrome of menopause in women. Front. Cell. Infect. Microbiol. 2024; 14: 1402389. https://dx.doi.org/10.3389/fcimb.2024.1402389

7. Donders G.G.G., Akinosoglou K., Massie Z., Özçelik S. Review of current and emerging estrogen receptor agonists for vaginal atrophy. Expert Opin. Pharmacother. 2025; 26(3): 249-55. https://dx.doi.org/10.1080/14656566.2025.2451150

8. Jaisamrarn U., Triratanachat S., Chaikittisilpa S., Grob P., Prasauskas V., Taechakraichana N. Ultra-low-dose estriol and lactobacilli in the local treatment of postmenopausal vaginal atrophy. Climacteric. 2013; 16(3): 347-55. https://dx.doi.org/10.3109/13697137.2013.769097

9. Panay N., Fenton A., Hamoda H., Hillard T., Islam R.M., Pedder H. et al.; IMS Recommendations Writing Group. International Menopause Society (IMS) recommendations and key messages on women’s midlife health and menopause. Climacteric. 2025; 28(6): 634-56. https://dx.doi.org/10.1080/ 13697137.2025.2585487

10. National Institute for Health and Care Excellence (NICE). Menopause: identification and management. NICE guideline NG23. London: NICE; 2024. Available at: https://www.nice.org.uk/guidance/ng23

11. Briggs P., on behalf of the Medical Advisory Council of the British Menopause Society. Genitourinary Syndrome of Menopause (GSM): BMS Consensus Statement. London: British Menopause Society; 2025.

12. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause. 2020; 27(9): 976-92. https://dx.doi.org/10.1097/GME.0000000000001609

13. British Society for Sexual Medicine (BSSM). Position statement for management of genitourinary syndrome of the menopause. London: BSSM; 2024. Available at: https://www.bssm.org.uk

14. Министерство здравоохранения Российской Федерации. Клинические рекомендации. Менопауза и климактерическое состояние у женщины. 2025. Доступно по: https://roag-portal.ru/recommendations_gynecology

15. Инструкция по применению лекарственного препарата для медицинского применения «Гинофлор Э». Регистрационный номер: ЛСР-008765/09. Доступно по: https://gynoflor.ru/instruction/?ysclid=mqtd484p24854045998

16. Moore K.H., Ognenovska S., Chua X.Y., Chen Z., Hicks C., El-Assaad F. et al. Change in microbiota profile after vaginal estriol cream in postmenopausal women with stress incontinence. Front. Microbiol. 2024; 15: 1302819. https://dx.doi.org/10.3389/fmicb.2024.1302819

17. Perelmuter S., Burns R., Shearer K., Grant R., Soogoor A., Jun S. et al. Genitourinary syndrome of lactation: a new perspective on postpartum and lactation-related genitourinary symptoms. Sex. Med. Rev. 2024; 12(3): 279-87. https://dx.doi.org/10.1093/sxmrev/qeae034

18. Smith P.E., McLaughlin E.M., Pandya L.K., Hade E.M., Lynch C.D., Hudson C.O. A pilot randomized controlled trial of vaginal estrogen on postpartum atrophy, perineal pain, and sexual function. Int. Urogynecol. J. 2022; 33(12): 3383-90. https://dx.doi.org/10.1007/s00192-022-05149-x

19. Аполихина И.А., Тетерина Т.А., Сулейманова Ж.Ж., Девяткина А.Р., Гасанова А.Р. Генитоуринарный лактационный синдром. Акушерство и гинекология. 2025; 1: 98-105. https://dx.doi.org/10.18565/aig.2024.320

20. Muzny C.A., Laniewski P., Schwebke J.R., Herbst-Kralovetz M.M. Host-vaginal microbiota interactions in the pathogenesis of bacterial vaginosis. Curr. Opin. Infect. Dis. 2020; 33(1): 59-65. https://dx.doi.org/10.1097/QCO.0000000000000620

21. Verwijs M.C., Agaba S.K., Darby A.C., van de Wijgert J.H.H.M. Impact of oral metronidazole treatment on the vaginal microbiota and correlates of treatment failure. Am. J. Obstet. Gynecol. 2020; 222(2): 157.e1-157.e13. https://dx.doi.org/10.1016/j.ajog.2019.08.008

22. Abavisani M., Sahebi S., Dadgar F., Peikfalak F., Keikha M. The role of probiotics as adjunct treatment in the prevention and management of gynecological infections: an updated meta-analysis of 35 RCT studies. Taiwan J. Obstet. Gynecol. 2024; 63(3): 357-68. https://dx.doi.org/10.1016/j.tjog.2024.03.004

23. Amabebe E., Anumba D.O.C. The vaginal microenvironment: the physiologic role of Lactobacilli. Front. Med. (Lausanne). 2018; 5: 181. https://dx.doi.org/10.3389/ fmed.2018.00181

Поступила 03.06.2026

Принята в печать 25.06.2026